Chinese Companies Develop 87 Vaccines, 35 Anti-Tumor Drugs, 38 Gene Therapies, 150 Synthetic Meds
This article was originally published in PharmAsia News
Executive Summary
Currently, drugs being developed by China’s 201 listed pharma companies spread across multiple categories with a total of 87 for vaccines, 35 for anti-tumor drugs, 38 for genetic engineering treatments, and 150 for synthetic medicines.